Agilent Surges to a New High as Growth Broadens

• Our read: EasyAlpha grades Agilent Technologies Inc B, indicating good quality against healthcare peers in the S&P 500, with liquidity as its strongest scored dimension and momentum as the key area to monitor.
• The day: The stock rose 4.6% to close at $172.85, marking a sharp move to a new 52-week peak after management highlighted multi-year replacement cycles and expanding laboratory demand.
• Watching: How the shares trade relative to the prior 52-week high of $168.94 as the price nears the consensus analyst target of $175.43.

Agilent Technologies surged 4.6% on Thursday, September 24, finishing at $172.85 in its seventh-largest single-day advance over the past year. The catalyst followed executive remarks at an investor conference, where management detailed improving momentum across core end markets. Leadership emphasized that the company is in the early stages of multi-year replacement cycles for liquid and gas chromatography instruments, while also benefiting from stabilizing demand in China.

The positive conference commentary reinforced momentum from recent quarterly performance, which previously prompted multiple analysts to lift price targets and earnings estimates.

Agilent carried a B quality grade from EasyAlpha into the session, signaling good quality that outscores most healthcare peers in the S&P 500. The company delivers a return on equity of 21.0% and a profit margin of 19.5%, backed by latest quarterly revenue growth of +8.1%. Relative to peers, liquidity stands as the company's strongest dimension. Historically, companies graded A or B have maintained stronger fundamentals and carried a lower risk of large drawdowns than those graded D or E.

The rapid advance has also tightened valuation multiples and elevated near-term expectations. Over the past month, the stock is +11.7%, bringing its move so far this year to +27.0% and pushing the price 59.8% above its 52-week low of $108.14. The shares now trade at 33.0 times trailing earnings and 24.1 times forward earnings. Wall Street remains constructive, with 72.7% of 22 covering analysts maintaining buy ratings, though the average target of $175.43 leaves a narrow upside gap of 1.5%. The shares now trade above their prior 52-week high of $168.94, with momentum representing the primary area to monitor.